« previous next »

Author Question: A patient has been taking a progestin-only, or minipill, OC for 3 months and reports spotting and ... (Read 58 times)

nautica902

  • Hero Member
  • *****
  • Posts: 591
on: Jul 23, 2018
A patient has been taking a progestin-only, or minipill, OC for 3 months and reports spotting and irregular menstrual cycles. The nurse will:
 
  a. question the patient about any possible missed doses of the pill.
  b. reassure the patient that this is normal with this form of contraception.
  c. recommend that she take a pregnancy test to rule out pregnancy.
  d. suggest that she use a backup form of contraception until these symptoms re-solve.

Question 2

An older adult patient has confusion, memory loss, and disorientation in familiar surroundings. The patient has been taking donepezil Aricept 10 mg once daily for 6 months.
 
  The patient's symptoms have begun to worsen, and the patient's spouse asks if the medication dose can be in-creased. What will the nurse tell the spouse? a. The dose can be increased, because the patient has been taking the drug for longer than 3 months.
  b. The dose can be increased to twice daily dosing instead of once daily dosing.
  c. The increase in symptoms is the result of hepatotoxicity from the medication's side effects.
  d. The patient must take the drug for longer than 1 year before the dose can be in-creased.


srodz

  • Sr. Member
  • ****
  • Posts: 333
Reply #1 on: Jul 23, 2018
Answer to Question 1

B
Patients taking the progestin-only OC may expect irregular bleeding, including spotting and ir-regular periods. This symptom does not indicate lack of compliance with the regimen. A preg-nancy test is not indicated. It is not necessary to use a backup form of contraception.

Answer to Question 2

A
Donepezil is given for mild, moderate, and severe AD, and dosing may be increased, although it must be titrated up slowly. For patients with moderate to severe AD who have taken 10 mg once daily for at least 3 months, the dose can be increased to 23 mg once daily. Donepezil is not given twice daily. Donepezil does not cause hepatotoxicity; hepatotoxicity occurs with tacrine, the first acetylcholinesteras e (AChE) inhibitor, which now is rarely used. Dosing is increased after 3 months, not 1 year.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
« previous next »
 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Bronchoscopy. Figure illustrates physician using a bronchoscope to inspect the patient’s bronchial t Bronchoscopy. Figure illustrates physician using a bronchoscope to inspect the patient’s bronchial t
Patient with osteoarthritis Patient with osteoarthritis
Building competency in patient centered care Building competency in patient centered care
A hearing-impaired patient using an interpreter. A hearing-impaired patient using an interpreter.
The relationship of substrate con- version (as measured by optical density) to the amount of patient ... The relationship of substrate con- version (as measured by optical density) to the amount of patient ...
Jaundice seen in the eyes and the skin of a patient with hepatitis A. Jaundice seen in the eyes and the skin of a patient with hepatitis A.
Video: Cytotoxic T cell receptors, activation, proliferation, differentiation & action

For a complete list of videos, visit our video library